• Profile
Close

Extensive serum cytokine analysis in patients with prostate cancer

Cytokine Aug 24, 2019

Gong D, Wang Y, Wang Y, et al. - Researchers sought to define targets, other than prostate specific antigen and prostate cancer antigen 3, for the diagnosis, prognosis, and prediction of therapeutic response in prostate cancer (CaP). For this purpose, they used a solid-phase antibody array, which can simultaneously identify 200 proteins, for the screening of novel blood-based biomarkers. Using the enzyme-linked immunosorbent assay, validation was sought for the identified targets. They discovered 38 proteins. Insulin, SDF-1a, CD40L, IL-18 and NCAM-1 were identified as the top five cytokines interacting with most other cytokines, indicating the significance of these five targets in the pathogenesis of CaP. These five targets showed more sensitivity for the early diagnosis and prognosis of CaP, and therefore, could serve as more effective therapeutic targets. Overall, new serum biomarkers for CaP may be found in the 38 differentially expressed cytokines identified in this study.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay